[Synergism of c-myc and p16 in oral squamous cell carcinoma]

Ai Zheng. 2004 Jun;23(6):635-9.
[Article in Chinese]

Abstract

Background & objective: The study on the protein expression of c-myc and p16 in oral squamous cell carcinoma (OSCC) has been reported, and a few researches involved in their gene amplification and mRNA expression in OSCC, however, the synergism of c-myc and p16 in OSCC in multiple levels is still unclear. This study aims to probe the synergism of c-myc and p16 in OSCC in gene amplification, mRNA expression, and protein expression levels.

Methods: The gene amplification, expression of mRNA, and protein of c-myc and p16 in 30 cases of OSCC were determined by in situ hybridization and immunohistochemical techniques.

Results: The amplification rate of c-myc was 63.3%, but no amplification of p16 was found in OSCC. The mRNA expression rates of c-myc and p16 were 83.3% and 93.3%, and their protein expression rates were 60.0% and 86.7%, respectively. The correlation analysis showed that there was significant correlativity between p16 and c-myc both in mRNA expression (r=0.676 5, P=4.055 6E-05) and in protein expression (r=0.564 2, P=0.001 2).

Conclusion: The gene amplification and overexpression of c-myc plays an important role in the tumorigenesis and development of OSCC. There is certain internal relationship between p16 and c-myc expression in OSCC.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / metabolism
  • Cyclin-Dependent Kinase Inhibitor p16 / biosynthesis*
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • Female
  • Gene Amplification
  • Gene Expression Regulation, Neoplastic
  • Genes, myc*
  • Genes, p16*
  • Humans
  • Male
  • Middle Aged
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / metabolism
  • Proto-Oncogene Proteins c-myc / biosynthesis*
  • Proto-Oncogene Proteins c-myc / genetics
  • RNA, Messenger / genetics

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger